The Phase I Study of HS-10509 in Chinese Adult Subjects

NCT06301074 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: HS-10509
DRUG: Placebo

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.